Welcome!

The Maryland and District of Columbia Society of Clinical Oncology, Inc. (“MDCSCO”) is committed to improving the quality and delivery of care in medical oncology in the State of Maryland and the District of Columbia. We promote appropriate standards of care in oncology and cooperate with investigators conducting cancer research.

In addition, we assist in the continuing education of oncologists and educate the public, the government, insurance carriers, and other health care providers about appropriate prevention of cancer and other therapeutic options for patients with cancer.

We encourage you to join more than 250 current members in providing the leadership in our progressive future. Click here to find out more about our membership.

Click to see the latest News & Publications

Membership Benefits

Membership is Now FREE for Professional
Members and for Allied Professionals.
Click here to join!

IMPORTANT NOTICE TO ONCOLOGISTS

NO MORE DUES!

The Maryland and District of Columbia Society of Clinical Oncology now offers FREE professional memberships to physician oncologists. Click here for the flyer.

As a member, you get the following benefits:

Free attendance at ALL MDCSCO events.
A legislative voice on issues of high priority to the practice of oncology.
Being a member of one of the U.S.'s strongest ASCO state affiliates and representation at ASCO.
Representation at NCCN.
Opportunity to be considered for elected office and other leadership roles within MDCSCO.

Confirm your membership now!

APPLY FOR ASCO'S HEALTH POLICY LEADERSHIP DEVELOPMENT PROGRAM

Applications are now open for the 2019-2020 ASCO Health Policy Leadership Development Program (HP-LDP). Formerly the Health Policy Fellowship Program, the HP-LDP is a one-year program that provides an opportunity for ASCO members to develop expertise in health policy, advocacy, and grassroots activity.

Application deadline is September 25, 2018 (11:59pm ET).

Click here for more.

Upcoming Meetings

September 26 - Industry hosted event
Details to be Announced

Click here to view full meeting information

October 24 - Annual Membership Meeting and Awards

Click here to view full meeting information

Two Cancer Research Organizations Submit Recommendations to FDA Aimed at Reducing Barriers to Clinical Trial Participation
On August 8, ASCO and Friends of Cancer Research (Friends) submitted to the Food and Drug Administration (FDA) recommended language for five guidance documents on ways to broaden eligibility criteria for cancer clinical trials.

Click here for more.

Corporate Members

Quick Links

PR Newswire

Affiliates

Oncology Practice Conference in September—Register by August 22
The conference is designed to address challenges that oncology practices face by discussing best practices and strategies to deliver high-quality, cost-effective care. As OPC Planning Committee Chair Robin Zon, MD, FACP, FASCO, who opened last year’s conference, stated, “Oncology practices face many challenges in the current dynamic environment. The goal of the ASCO Oncology Practice Conference is to address these issues by sharing best practices and strategies to preserve the delivery of high-quality, cost-effective care.”

Click here for more Information.